Table of Contents Author Guidelines Submit a Manuscript
Journal of Lipids
Volume 2011, Article ID 549137, 6 pages
http://dx.doi.org/10.1155/2011/549137
Research Article

LDL-C/HDL-C Ratio Predicts Carotid Intima-Media Thickness Progression Better Than HDL-C or LDL-C Alone

1Division of Cardio-Vascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan
2Department of Community Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan

Received 24 February 2011; Revised 25 April 2011; Accepted 14 May 2011

Academic Editor: Angeliki Chroni

Copyright © 2011 Mika Enomoto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Assmann and H. Schulte, “Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience),” American Journal of Cardiology, vol. 70, no. 7, pp. 733–737, 1992. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Tanne, S. Yaari, and U. Goldbourt, “High-density lipoprotein cholesterol and risk of ischemic stroke mortality: a 21-year follow-up of 8586 men from the Israeli Ischemic Heart Disease Study,” Stroke, vol. 28, no. 1, pp. 83–87, 1997. View at Google Scholar · View at Scopus
  3. W. P. Castelli, K. Anderson, P. W. Wilson, and D. Levy, “Lipids and risk of coronary heart disease. The Framingham Study,” Annals of Epidemiology, vol. 2, no. 1-2, pp. 23–28, 1992. View at Google Scholar · View at Scopus
  4. P. Amarenco, J. Labreuche, P. Lavallée, and P. J. Touboul, “Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis,” Stroke, vol. 35, no. 12, pp. 2902–2909, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Amarenco, L. B. Goldstein, M. Szarek et al., “Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack. The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial,” Stroke, vol. 38, no. 12, pp. 3198–3204, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. S. J. Nicholls, E. M. Tuzcu, I. Sipahi et al., “Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis,” Journal of the American Medical Association, vol. 297, no. 5, pp. 499–508, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J.P. Kastelein, W. A. van der Steeg, I. Holme et al., “Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment,” Circulation, vol. 117, no. 23, pp. 3002–3009, 2008. View at Publisher · View at Google Scholar
  8. P. Amarenco, L. B. Goldstein, A. Callahan III et al., “Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial,” Atherosclerosis, vol. 204, no. 2, pp. 515–520, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Ray, C. P. Cannon, R. Cairns, D. A. Morrow, P. M. Ridker, and E. Braunwald, “Prognostic utility of ApoB/AI, total cholesterol/HDL, Non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes. Results from PROVE IT-TIMI 22,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 3, pp. 423–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. M. Ridker, N. Rifai, N. R. Cook, G. Bradwin, and J. E. Buring, “Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women,” Journal of the American Medical Association, vol. 294, no. 3, pp. 326–333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Barter, A. M. Gotto, J. C. LaRosa et al., “HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events,” New England Journal of Medicine, vol. 357, no. 13, pp. 1301–1310, 2007. View at Publisher · View at Google Scholar
  12. B. A. P. Phan, B. Chu, N. Polissar, T. S. Hatsukami, C. Yuan, and X. Q. Zhao, “Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging,” International Journal of Cardiovascular Imaging, vol. 23, no. 3, pp. 337–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. O. T. Raitakari, M. Juonala, M. Kähönen et al., “Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood,” Journal of the American Medical Association, vol. 290, no. 17, pp. 2277–2283, 2003. View at Publisher · View at Google Scholar
  14. A. Hino, H. Adachi, K. Toyomasu et al., “Very long chain N-3 fatty acids intake and carotid atherosclerosis: an epidemiological study evaluated by ultrasonography,” Atherosclerosis, vol. 176, no. 1, pp. 145–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Nakajima, M. Okazaki, A. Tanaka et al., “Separation and determination of remnant-like particles in human serum using monoclonal antibodies to apo B-100 and apo A-I,” Journal of Clinical Ligand Assay, vol. 19, no. 3, pp. 177–183, 1996. View at Google Scholar · View at Scopus
  16. D. H. O'Leary, J. F. Polak, R. A. Kronmal, T. A. Manolio, G. L. Burke, and S. K. Wolfson, “Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults,” New England Journal of Medicine, vol. 340, no. 1, pp. 14–22, 1999. View at Publisher · View at Google Scholar
  17. W. A. van der Steeg, S. M. Boekholdt, E. A. Stein et al., “Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk,” Annals of Internal Medicine, vol. 146, no. 9, pp. 640–648, 2007. View at Google Scholar · View at Scopus
  18. E. Ingelsson, E. J. Schaefer, J. H. Contois et al., “Clinical utility of different lipid measures for prediction of coronary heart disease in men and women,” Journal of the American Medical Association, vol. 298, no. 7, pp. 776–785, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Juonala, J. S. A. Viikari, M. Kahonen et al., “Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood,” Journal of the American College of Cardiology, vol. 52, no. 4, pp. 293–299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kurabayashi and T. Yamazaki, “Superior benefit of aggressive lipid-lowering therapy for high-risk patients using statins: the SUBARU study,” Journal of Atherosclerosis and Thrombosis, vol. 15, no. 6, pp. 314–323, 2008. View at Google Scholar
  21. B. Pitt, R. P. Byington, C. D. Furberg et al., “Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events,” Circulation, vol. 102, no. 13, pp. 1503–1510, 2000. View at Google Scholar · View at Scopus
  22. T. J. Smilde, S. van Wissen, H. Wollersheim, M. D. Trip, J. J. Kastelein, and A. F. H. Stalenhoef, “Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial,” Lancet, vol. 357, no. 9256, pp. 577–581, 2001. View at Publisher · View at Google Scholar · View at Scopus